NCT07103720View on ClinicalTrials.gov

The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 24, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

October 30, 2026

Conditions
Allergy
Interventions
DIAGNOSTIC_TEST

Skin Testing

Participants will undergo skin prick testing and intradermal test injections at 5 increasing concentrations of midazolam, ketamine and/or ondansetron during one single study visit.

Trial Locations (1)

85268

Mayo Clinic Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Arizona Biomedical Research Commission (ABRC)

OTHER

lead

Mayo Clinic

OTHER